文献速递肝病

Gasdermin D 在人及小鼠中作为非酒精性脂肪性肝炎细胞焦亡执行蛋白发挥关键作用

Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
PubMed 文献 · J Hepatol · 2017-12-20

研究检测了非酒精性脂肪性肝病(NAFLD)患者肝组织中 Gasdermin D(GSDMD)的表达,并利用 Gsdmd 基因敲除小鼠、db/db 肥胖小鼠及 MCD 或高脂饮食模型探讨 GSDMD 在脂肪性肝炎发病中的作用。结果显示 GSDMD 及其焦亡诱导片段 GSDMD-N 在人 NAFLD/NASH 肝组织中上调,GSDMD-N 水平与 NAFLD 活动度评分及纤维化相关,Gsdmd 敲除减轻小鼠脂肪性肝炎,而肝细胞过表达 GSDMD-N 加重病变。

要点

  • 人 NAFLD/NASH 肝组织中 GSDMD 及焦亡片段 GSDMD-N 表达上调。
  • 人 NASH 肝组织 GSDMD-N 蛋白水平与 NAFLD 活动度评分及纤维化相关。
  • Gsdmd 敲除小鼠 MCD 饮食后脂肪变性和炎症较野生型同窝小鼠减轻。

核心结论

  • GSDMD 作为细胞焦亡执行蛋白,通过调控细胞因子分泌、NF-ĸB 激活和脂肪生成,在脂肪性肝炎发病中起关键作用。

研究设计与样本

  • 研究检测人 NAFLD 患者及对照肝组织 GSDMD 表达,并使用 Gsdmd 敲除小鼠、db/db 肥胖小鼠及野生型同窝小鼠,以 MCD 或对照饮食诱导脂肪性肝炎。
  • Gsdmd 敲除与野生型小鼠还用于高脂饮食诱导的 NAFLD 模型。
  • Alb-Cre 小鼠给予表达 gasdermin-N 结构域的 AAV 载体(AAV9-FLEX-GSDMD-N)并喂饲 MCD 或对照饮食 10 天。

主要发现

  • 人 NAFLD/NASH 肝组织中 GSDMD 及其焦亡诱导片段 GSDMD-N 上调。
  • 人 NASH 肝组织 GSDMD-N 蛋白水平显著高于对照,并与 NAFLD 活动度评分和纤维化相关。
  • MCD 喂养的 Gsdmd 敲除小鼠较野生型同窝小鼠脂肪变性和炎症严重程度减轻。
  • GSDMD 与促炎细胞因子(IL-1β、TNF-α 和 MCP-1 [CCL2])分泌及 NF-ĸB 信号通路持续激活相关。
  • Gsdmd 敲除小鼠脂肪变性较低,主要因脂肪生成基因 Srebp1c(Srebf1)表达降低及脂肪分解基因 Pparα、Aco [Klk15]、Lcad [Acadl]、Cyp4a10 和 Cyp4a14 表达上调。

关键数值与推荐

  • 肝 GSDMD-N 蛋白水平在 NASH 与对照间比较,原文报告为显著升高,并与 NAFLD 活动度评分和纤维化相关。
  • GSDMD-N 仍是诊断 NASH 的潜在生物标志物。

临床怎么用

  • 原文结论提示 GSDMD 通过调控脂肪生成、炎症反应和 NF-ĸB 信号通路在 NASH 发病中起关键作用,揭示了人类 NASH 的潜在治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Gasdermin D (GSDMD)-executed programmed necrosis is involved in inflammation and controls interleukin (IL)-1β release. However, the role of GSDMD in non-alcoholic steatohepatitis (NASH) remains unclear. We investigated the role of GSDMD in the pathogenesis of steatohepatitis. METHODS: Human liver tissues from patients with non-alcoholic fatty liver disease (NAFLD) and control individuals were obtained to evaluate GSDMD expression. Gsdmd knockout (Gsdmd-/-) mice, obese db/db mice and their wild-type (WT) littermates were fed with methionine-choline deficient (MCD) or control diet to induce steatohepatitis. The Gsdmd-/- and WT mice were also used in a high-fat diet (HFD)-induced NAFLD model. In addition, Alb-Cre mice were administered an adeno-associated virus (AAV) vector that expressed the gasdermin-N domain (AAV9-FLEX-GSDMD-N) and were fed with either MCD or control diet for 10 days. RESULTS: GSDMD and its pyroptosis-inducing fragment GSDMD-N were upregulated in liver tissues of human NAFLD/NASH. Importantly, hepatic GSDMD-N protein levels were significantly higher in human NASH and correlated with the NAFLD activity score and fibrosis. GSDMD-N remained a potential biomarker for the diagnosis of NASH. MCD-fed Gsdmd-/- mice exhibit decreased severity of steatosis and inflammation compared with WT littermates. GSDMD was associated with the secretion of pro-inflammatory cytokines (IL-1β, TNF-α, and MCP-1 [CCL2]) and persistent activation of the NF-ĸB signaling pathway. Gsdmd-/- mice showed lower steatosis, mainly because of reduced expression of the lipogenic gene Srebp1c (Srebf1) and upregulated expression of lipolytic genes, including Pparα, Aco [Klk15], Lcad [Acadl], Cyp4a10 and Cyp4a14. Alb-Cre mice administered with AAV9-FLEX-GSDMD-N showed significantly aggravated steatohepatitis when fed with MCD diet. CONCLUSION: As an executor of pyroptosis, GSDMD plays a key role in the pathogenesis of steatohepatitis, by controlling cytokine secretion, NF-ĸB activation, and lipogenesis. LAY SUMMARY: Non-alcoholic fatty liver disease has become one of the most feared chronic liver diseases, because it is the most rapidly growing indication for adult liver transplantation and a major cause of hepatocellular carcinoma. However, the mechanisms involved in the transformation of simple steatosis to steatohepatitis remain unclear. Herein, we show that gasdermin D driven pyroptosis is prominent in patients with non-alcoholic steatohepatitis (NASH), and gasdermin-N domain remains a potential biomarker for the diagnosis of NASH. Gasdermin D plays a key role in the pathogenesis of NASH by regulating lipogenesis, the inflammatory response, and the NF-ĸB signaling pathway, revealing potential treatment targets for NASH in humans.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Xu B, Jiang M, Chu Y, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2017. PMID: 29273476. doi:10.1016/j.jhep.2017.11.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。